KLG Stock +78.58% In 3 Months Since We Picked KLG Stock +78.58% In 3 Months Since We Picked Unlock All Top Buy Picks

Range Low Price High Price Comment
30 days $12.82 $19.54 Friday, 26th Apr 2024 MGNX stock ended at $14.56. This is 1.32% more than the trading day before Thursday, 25th Apr 2024. During the day the stock fluctuated 7.31% from a day low at $14.22 to a day high of $15.26.
90 days $12.82 $21.88
52 weeks $4.29 $21.88

Historical MacroGenics prices

Date Open High Low Close Volume
Feb 14, 2024 $16.62 $17.70 $16.60 $17.13 970 225
Feb 13, 2024 $16.98 $17.48 $16.69 $17.35 1 058 455
Feb 12, 2024 $17.56 $18.44 $17.52 $17.92 1 271 185
Feb 09, 2024 $18.31 $18.73 $16.77 $17.32 1 846 840
Feb 08, 2024 $17.36 $18.85 $17.31 $18.30 1 984 307
Feb 07, 2024 $17.34 $18.10 $17.01 $17.43 2 186 433
Feb 06, 2024 $16.75 $17.31 $16.37 $17.26 1 361 087
Feb 05, 2024 $15.33 $16.85 $15.31 $16.75 1 730 148
Feb 02, 2024 $15.14 $15.87 $14.92 $15.45 1 898 258
Feb 01, 2024 $14.40 $15.37 $14.07 $15.27 1 679 626
Jan 31, 2024 $13.86 $14.76 $13.72 $14.30 1 714 193
Jan 30, 2024 $13.54 $14.04 $13.38 $14.00 1 245 236
Jan 29, 2024 $13.17 $13.82 $12.87 $13.64 1 184 800
Jan 26, 2024 $12.88 $13.46 $12.50 $13.22 1 180 973
Jan 25, 2024 $12.33 $12.99 $12.25 $12.80 903 285
Jan 24, 2024 $12.55 $12.60 $11.73 $12.01 697 764
Jan 23, 2024 $12.16 $12.70 $11.94 $12.01 954 646
Jan 22, 2024 $12.10 $12.47 $11.93 $12.11 1 082 769
Jan 19, 2024 $10.83 $12.10 $10.77 $12.00 1 662 094
Jan 18, 2024 $10.69 $10.82 $10.16 $10.75 780 064
Jan 17, 2024 $10.73 $10.96 $10.18 $10.55 1 027 622
Jan 16, 2024 $10.51 $11.18 $10.42 $10.91 934 207
Jan 12, 2024 $10.42 $10.99 $10.42 $10.70 646 840
Jan 11, 2024 $10.70 $10.77 $10.09 $10.30 761 929
Jan 10, 2024 $10.13 $10.95 $9.88 $10.85 1 430 306
Click to get the best stock tips daily for free!

About MacroGenics

MacroGenics MacroGenics, Inc., a biopharmaceutical company, develops and commercializes antibody-based therapeutics to treat cancer in the United States. Its approved product is MARGENZA (margetuximab-cmkb), a human epidermal growth factor receptor 2 (HER2) receptor antagonist indicated, in combination with chemotherapy, for the treatment of adult patients with metastatic HER2-positive breast cancer who have received two or more prior anti-HER2 regimens. The... MGNX Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT